Slovak Republic
Global Fin Swe Nor Den Ger Cze Svk Pol Hun USA
  • Logo
  • Produkty
  • O nás
  • Novinky
  • Kontaktujte nás
  • Kariéra
Vyhľadávanie
Logo
  • COVID-19
    • Testy COVID-19
      • Biosynex COVID-19 Ag Test
  • POCT
    • QuikRead go
      • QuikRead go prístroj
      • QuikRead go easy CRP
      • QuikRead go CRP
      • QuikRead go CRP+Hb
      • QuikRead go wrCRP
      • QuikRead go wrCRP+Hb
      • QuikRead go HbA1c
      • QuikRead go Strep A
      • QuikRead go iFOBT
      • QuikRead go príslušenstvo
    • QuikRead
      • QuikRead 101 prístroj
      • QuikRead CRP
      • QuikRead U-ALB
      • QuikRead 101 príslušenstvo
    • microINR
      • microINR
  • Molekulárna Dx onkológia
    • BioNTech Diagnostics
      • MammaTyper®
Logo
Zavrieť
  • Produkty
    • COVID-19
      • Testy COVID-19
        • Biosynex COVID-19 Ag Test
    • POCT
      • QuikRead go
        • QuikRead go prístroj
        • QuikRead go easy CRP
        • QuikRead go CRP
        • QuikRead go CRP+Hb
        • QuikRead go wrCRP
        • QuikRead go wrCRP+Hb
        • QuikRead go HbA1c
        • QuikRead go Strep A
        • QuikRead go iFOBT
        • QuikRead go príslušenstvo
      • QuikRead
        • QuikRead 101 prístroj
        • QuikRead CRP
        • QuikRead U-ALB
        • QuikRead 101 príslušenstvo
      • microINR
        • microINR
    • Molekulárna Dx onkológia
      • BioNTech Diagnostics
        • MammaTyper®
  • O nás
  • Novinky
  • Kontaktujte nás
  • Kariéra

Navrhované témy

antibiotic resistance CRP point-of-care

Obľúbené produkty

Biosynex COVID-19 Ag Test

Biosynex COVID-19 Ag Test

QuikRead go HbA1c

QuikRead go HbA1c

QuikRead go easy CRP

QuikRead go easy CRP

Najnovšie správy

Zobraziť všetko

Antigen testing and CRP can help to low COVID-burden in elderly care.

15. decembra 2020 | Novinky, COVID-19

It is highly important to continue iFOBT testing during COVID-19

9. decembra 2020

A significant decrease in Urinary tract infection (UTI) diagnoses due to the COVID-19 pandemic raises concern

1. decembra 2020 | AMR, COVID-19

  • Zobraziť všetko
  • Neboli nájdené žiadne výsledky
  • Loading...

Správy

Antigen testing and CRP can help to low COVID-burden in elderly care.

15. decembra 2020 | Novinky, COVID-19

It is highly important to continue iFOBT testing during COVID-19

9. decembra 2020

Späť na všetky novinky
17. apríla 2020
Novinky,
AMR

Antimicrobial resistance (AMR) has a role in COVID-19

Antimicrobial resistance (AMR) has a role in COVID-19

Antimicrobial resistance (AMR) is an important threat to global health1. AMR should not be overlooked despite understandable focus on the ongoing COVID-19 pandemic. An increasing body of opinion indicates that AMR may have a role in COVID-192-4.

Firstly, a significant number of the deceased COVID-19 patients have had secondary bacterial infections like is common for other several viral infections5-9. In severe viral respiratory infections, the immune system is weakened, and respiratory system exposed to other pathogens. In such cases, if a hospitalized patient is infected with resistant bacteria, consequences can be fatal. There are indications of increase in resistant bacterial infections such as MRSA in hospitals during the outbreaks of novel emerging pathogens such as previous SARS epidemics10,11. It bears further investigation if the resistant bacteria have influenced the COVID-19 situation for example in Italy, where hospitals have been shown to have significant AMR-related problems12.

Secondly, prophylactic antibiotics are often used to prevent secondary bacterial infections of the hospitalized patients as is the case also in COVID-197,8,13-15. This can significantly increase the use of antibiotics during the pandemic and silently cause the emergence of resistant bacteria, as was recently commented by Prof. Anu Kantele from University of Helsinki4.

The actual role of antimicrobial resistance in COVID-19 may be revealed in the future. However, AMR as such is an important threat to global health although it develops more silently compared to COVID-19. The fight against AMR calls for collective global actions on various levels, as has now been rapidly done in COVID-19.1, 2, 16, 17.

References
  1. WHO. Global action plan on Antimicrobial Resistance 2015. Available at WHO: Global action plan on antimicrobial resistance 2015.
  2. Kirchhelle et al. Opinion: Antibiotic Resistance Could Lead to More COVID-19 Deaths. Scientific American 2020. April 1. https://blogs.scientificamerican.com/observations/antibiotic-resistance-could-lead-to-more-covid-19-deaths/?amp, accessed 15.4.2020
  3. Aftenposten. Derfor tar koronaviruset så mange liv i Italia | Erik Martiniussen. Article in Norwegian. https://www.aftenposten.no/article/ap-awEP27.html , accessed 15.4.2020
  4. Helsingin Sanomat. Antibioottien runsas käyttö saattaa selittää Italian koronavirus­kuolemien määrää. 5.4.2020. Article in Finnish. https://www.hs.fi/tiede/art-2000006464588.html, accessed 15.4.2020
  5. Wang L et al. Coronavirus Disease 2019 in elderly patients: characteristics and prognostic factors based on 4-week follow-up. J Infect. 2020. Mar 30. doi: 10.1016/j.jinf.2020.03.019.
  6. Li et al. Clinical characteristics of 25 death cases with COVID-19: a retrospectivereview of medical records in a single medical center, Wuhan, China. Int J Infect Dis 2020. doi: https://doi.org/10.1016/j.ijid.2020.03.053
  7. Zhou et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020; 395: 1054–62.
  8. Huang et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395: 497–506.
  9. Centers for Disease Control and Prevention (CDC). Bacterial coinfections in lung tissue specimens from fatal cases of 2009 pandemic influenza A (H1N1) - United States, May-August 2009. MMWR Morb Mortal Wkly Rep. 2009; 58(38):1071-4.
  10. Yap et al. Increase in methicillin-resistant Staphylococcus aureus acquisition rate and change in pathogen pattern associated with an outbreak of severe acute respiratory syndrome. Clin Infect Dis. 2004; 39(4):511-6.
  11. Chai et al. Paradoxical Increase in Methicillin-Resistant Staphylococcus aureus Acquisition Rates Despite Barrier Precautions and Increased Hand Washing Compliance during an Outbreak of Severe Acute Repiratory Syndrome. Clin Infect Dis. 2005; 40(4): 632–633.
  12. European Centre for Disease Prevention and Control. ECDC country visit to Italy to discuss antimicrobial resistance issues. Stockholm: ECDC; 2017.
  13. Cao et al. Clinical Features and Short-term Outcomes of 102 Patients with Corona Virus Disease 2019 in Wuhan, China. Clin Infect Dis. 2020 Apr 2. doi: 10.1093/cid/ciaa243.
  14. Lupia et al. 2019 novel coronavirus (2019-nCoV) outbreak: A new challenge. J Glob Antimicrob Resist. 2020 Mar 7; 21:22-27. doi: 10.1016/j.jgar.2020.02.021.
  15. Wang et al. Clinical Features of 69 Cases with Coronavirus Disease 2019 in Wuhan, China. Clin Infect Dis. 2020 Mar 16. doi: 10.1093/cid/ciaa272.
  16. WHO. Strategic preparedness and response plan for the new coronavirus14.4.2020. https://www.who.int/publications-detail/covid-19-strategy-update-13-april-2020, Accessed 15.4.2020
  17. PEW. The Invaluable Role of Antibiotics—in a Pandemic and Beyond, 15.4.2020. https://www.pewtrusts.org/en/research-and-analysis/articles/2020/04/15/the-invaluable-role-of-antibiotics-in-a-pandemic-and-beyond?amp=1&__twitter_impression=true, Accessed 17.4.2020
Share
Facebook
Twitter
Email

Aidian Oy

Bělohorská 57,
169 00 Praha 6,
Česká republika

+421 944 313 888

Fakturačné adresy

IČ DPH 45769842

  • Kontaktujte nás
  • Kariéra
  • Produkty
    • QuikRead go
    • QuikRead
    • microINR
    • BioNTech Diagnostics
    • Testy COVID-19
  • Ochrana dát
    • Politika ochrany údajov
    • Vyhlásenie o ochrane súkromia
    • Zásady používania súborov cookie
    • Zásady pre používanie sociálnych sietí
    • Zákaz súhlas s priamym marketingom
Copyright © 2021 Aidian

Táto webová stránka používa cookies

Cookies používame na personalizáciu obsahu a reklám, na analýzu návštevnosti stránok a k zlepšovaniu našich služieb.

Spravovať

Nevyhnutné (povinný) (Požadovaný)

Tieto cookies sú nevyhnutné pre správne fungovanie stránok. Toto zahŕňa cookies pre prístup do zabezpečených oblastí a CSRF zabezpečenia. Upozorňujeme, že východiskové súbory cookies spoločnosti Craft nezhromažďujú žiadne osobné ani citlivé informácie. Craft predvolené súbory cookies nezhromažďujú IP adresy. Informácie, ktoré ukladajú, sa neposielajú spoločnostiam Pixel & Tonic ani žiadnym tretím stranám.
— CraftSessionId
Provider: this site
Expiration: Session
Description: Craft sa pri udržiavaní relácií naprieč webovým rozhraním spolieha na relácie PHP. To sa vykonáva pomocou cookie relácie PHP. Predvolené nastavenie Craft pomenováva tieto cookie ako "CraftSessionId", ale môžu byť premenované pomocou konfiguračného nastavenia phpSessionId. Platnosť cookie skončí, akonáhle vyprší platnosť relácie.
— *_identity
Provider: this site
Expiration: Persistent
Description: Keď sa prihlásite do ovládacieho panelu, dostanete overovací súbor cookie, ktorý sa používa na udržanie vášho overeného stavu. Názov cookie má predponu s dlhým, náhodne generovaným reťazcom, za ktorým nasleduje _identity. Súbor cookie ukladá iba informácie potrebné na udržanie zabezpečenej, overenej relácie a bude existovať len tak dlho, kým bude používateľ autorizovaný v Craft.
— *_username
Provider: this site
Expiration: Persistent
Description: Ak počas prihlásenia zaškrtnete možnosť "Ponechať ma prihláseného", používa sa tento súbor cookie na zapamätanie mena používateľa pre vaše ďalšie overenie.
— CRAFT_CSRF_TOKEN
Provider: this site
Expiration: Session
Description: Chráni nás i vás ako používateľa pred útokmi falšovania webových stránok (CSRF).

Štatistiky

Štatistické súbory cookies nám pomáhajú vďaka anonymnému zhromažďovaniu a hláseniu informácií porozumieť, ako sa návštevníci a webové stránky vzájomne ovplyvňujú.

Marketing

Marketingové cookies sú používané na sledovanie návštevníkov naprieč webovými stránkami. Zámerom je zobrazovať reklamy, ktoré sú relevantné a pútavé pre jednotlivého používateľa, a tým cennejšie pre vydavateľov a inzerentov tretích strán.
Skryť podrobnosti